Intra-Cellular Ther
(ITCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,325 | 35,151 | 15,646 | N/A | N/A |
| Marketable Securities | 68,321 | 2,000 | 3,500 | N/A | N/A |
| Receivables | 52 | 336 | 300 | N/A | N/A |
| TOTAL | $130,986 | $38,250 | $19,635 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 55 | 68 | 58 | N/A | N/A |
| Other Non-Current Assets | 71 | 132 | 131 | 0 | 0 |
| TOTAL | $126 | $200 | $189 | $N/A | $N/A |
| Total Assets | $131,112 | $38,449 | $19,824 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,053 | 3,395 | 42 | 0 | 0 |
| Accrued Expenses | 8,504 | 3,439 | 1,131 | N/A | N/A |
| TOTAL | $10,557 | $6,834 | $2,840 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 1,667 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,557 | $6,834 | $2,840 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,928 | 29,223 | N/A | N/A | N/A |
| Common Shares | 3 | 2 | 2 | N/A | N/A |
| Retained earnings | -88,256 | -57,565 | -30,696 | N/A | N/A |
| Other shareholders' equity | -105 | 0 | 0 | 0 | 0 |
| TOTAL | $120,555 | $31,615 | $16,984 | $N/A | $N/A |
| Total Liabilities And Equity | $131,112 | $38,449 | $19,824 | $0 | $0 |